The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20061047

Download in:

View as

General Info

PMID
20061047